Brisbane Clinical Trials
The Metabolism Study
The study drug is a potential new treatment for Urea cycle disorders (UCDs).
4 overnight stays + 3 sets of 3-nights inpatient stays nights
2 visits
Study Objective:
- To evaluate the efficacy of a new treatment aimed at enhancing the conversion of ammonia to urea in patients with urea cycle disorders (UCD).
Understanding UCD:
- UCDs are a collection of genetic anomalies that disrupt the normal conversion of ammonia into urea, resulting in elevated ammonia levels in the body, which can cause significant health complications.
Importance of Prevention:
- Managing ammonia levels is crucial for individuals with UCD. Current strategies include dietary protein restriction and ammonia-lowering agents.
- However, the development of additional treatments is essential for improved health outcomes.
Clinical Trial Details:
- An independent ethics committee has approved this clinical trial.
- Participants will be reimbursed for their time
Call us on 1800 243 733 to discuss your eligibility today!
Eligibility
Biological Sex Male or Female
BMI 18 - 32 kg/m²
Age 18-55 years old
Body Weight <110kg
Medical History No significant medical history
Medication Not taking any prescription medication (except for hormonal contraception and stable cholesterol and/or blood pressure medications)
Smoking History Non-smokers or smoking <5 cigarettes/day